Argentina's infant vaccination coverage surpassed 90% in 2025, according to official data from the Ministry of Health's Nomivac registry. The five 'trazadoras' vaccines for the first year of life—BCG, Hepatitis B neonatal, Quíntuple, IPV, and Neumococo—all exceeded the 90% threshold, with some reaching over 93%. Source: Clarín
While all sources agree on the positive trend, exact figures vary. Lavozar and Clarín report: BCG 93.5%, Hepatitis B neonatal 92%, Quíntuple 91.6%, IPV 91.3%, Neumococo 90.1%. Source: Lavozar Meanwhile, Infobae reports higher numbers: BCG 95.8%, Hepatitis B 92.4%, Quíntuple 91.9%, IPV 91.3%, Neumococo 90.4%. Source: Infobae The discrepancy may stem from different data cut-off dates or rounding.
Authorities attribute the improved data reliability to the Nomivac electronic registry, which associates each dose with a specific person, replacing aggregate counts. "The adoption of Nomivac implied a sincere reporting of the number of notified doses," the Ministry stated. Source: Infobae
Despite infant success, vaccines for children aged 5 and 11 lag. The Triple Viral booster rose from 46.7% to 54.8% Source: Lavozar, still far below the 90% target. For adolescents, VPH coverage reached 61.2% in women and 56.5% in men, while the VSR vaccine for pregnant women reached 74%. Source: Lavozar
“La vacuna contra el Virus Sincicial Respiratorio (VSR), en su segundo año de implementación, alcanzó una cobertura del 74%. Este dato representa un avance frente al 67,8% registrado durante el periodo anterior.”
“El refuerzo de la Triple Viral pasó del 46,7% en 2024 al 54,8% en 2025.”
““La adopción del NOMIVAC implicó un sinceramiento en la cantidad de dosis notificadas, ya que cada dosis queda asociada a una persona específica. Esto permitió dejar atrás la carga de vacunas aplicadas según números absolutos””